Quality of life in insulin-treated patients

Journal of the Japan Diabetes Society

Volumn 51, Issue 7, 2008, Pages 601-608

  Ishii, Hitoshi ^a   Furuya, Miyuki ^a   Iburi, Tadao ^a   Yamagami, Keiko ^b   Ishibashi, Rieko ^c   Tsujii, Satoru ^a  

^a TENRI HOSPITAL   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c OSAKA KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Hypoglycemia; Insulin therapy; Quality of life(QOL)

Indexed keywords

EID: 51149109844     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Japanese source
2. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L (2000) Use of insulin aspart, a fast-acting insulin analogue, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 23 : 583-588
3. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T (2000) Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 23 : 644-649
4. Yki-Jarvinen H, Dressler A, Ziemen M, The HOE901/3002 study group (2000) Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23 : 1130-1136
5. Japanese source
6. Japanese source
7. Japanese source